News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MannKind Corporation - Common Stock
(NQ:
MNKD
)
3.280
+0.040 (+1.23%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MannKind Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
March 10, 2025
From
MannKind
Via
GlobeNewswire
MannKind Stock Surges After-Hours On Q4 Revenue Beat, Debt Reduction As Retail Investors Celebrate ‘Amazing Comeback’
↗
February 27, 2025
The company significantly reduced its debt principal by $236 million, leaving just $36 million in remaining convertible debt, and ended 2024 with $203 million in cash, cash equivalents, and...
Via
Stocktwits
MannKind (MNKD) Q4 2024 Earnings Call Transcript
↗
February 27, 2025
MNKD earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 26, 2025
Conference call to provide corporate updates today at 4:30 pm ET
From
MannKind
Via
GlobeNewswire
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
MannKind's Earnings Outlook
↗
May 07, 2025
Via
Benzinga
MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025
May 01, 2025
From
MannKind
Via
GlobeNewswire
This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
↗
April 10, 2025
Via
Benzinga
MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options
April 07, 2025
From
MannKind
Via
GlobeNewswire
MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025
February 19, 2025
From
MannKind
Via
GlobeNewswire
MannKind to Present at Upcoming Investor Conferences
February 06, 2025
From
MannKind
Via
GlobeNewswire
MannKind Expands Executive Leadership Team
January 06, 2025
From
MannKind
Via
GlobeNewswire
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
↗
December 20, 2024
Via
Benzinga
Topics
Stocks
MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash
December 18, 2024
From
MannKind
Via
GlobeNewswire
MannKind Shares Are falling Today: What's Going On?
↗
December 16, 2024
MannKind Corporation (NASDAQ: MNKD) are trading lower Monday. The company released its six-month results from its Phase 3 INHALE-1 pediatric diabetes trial. Here's what you need to know.
Via
Benzinga
MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)
December 16, 2024
From
MannKind
Via
GlobeNewswire
CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India
December 11, 2024
From
MannKind
Via
GlobeNewswire
MannKind (MNKD) Q3 2024 Earnings Call Transcript
↗
November 07, 2024
MNKD earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update
November 07, 2024
From
MannKind
Via
GlobeNewswire
MannKind to Present at 2024 UBS Healthcare Conference
November 05, 2024
From
MannKind
Via
GlobeNewswire
MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases
November 04, 2024
From
MannKind
Via
GlobeNewswire
MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024
October 31, 2024
From
MannKind
Via
GlobeNewswire
Lytham Partners Announces KOL Panels and Participating Companies for its Fall 2024 Investor Conference
September 30, 2024
Phoenix, Arizona and New York, New York--(Newsfile Corp. - September 30, 2024) - Lytham...
Via
Newsfile
More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®)
September 30, 2024
From
MannKind
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
September 23, 2024
Via
Benzinga
MannKind Announces Clearance from PMDA to Initiate Phase 3 Clinical Trial (ICoN-1) in Japan Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease
September 18, 2024
From
MannKind
Via
GlobeNewswire
MannKind to Present at 2024 Cantor Fitzgerald Global Healthcare Conference
September 10, 2024
From
MannKind
Via
GlobeNewswire
Kohl's Posts Upbeat Q2 Earnings, Joins Box, Waldencast, AeroVironment And Other Big Stocks Moving Higher On Wednesday
↗
August 28, 2024
Via
Benzinga
MannKind to Present at Upcoming Conferences
August 27, 2024
From
MannKind
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
